ARUP Labs plans to begin offering Decode’s prostate cancer-risk test to clients nationwide in the fall, the companies said.
Over the last 20 years, the world has poured billions of dollars and hours into cancer research, plumbing the depths of our DNA in search of a cure. We’ve discovered causes, treatments and ways to diagnose and detect the disease, yet as of right now, the cure remains a mystery, hidden somewhere, many scientists say, in the complex workings of our nuclear DNA. Some experts, however, disagree. Some believe that the key to abolishing cancer lies in the much less studied mitochondrial DNA (mtDNA). Some believe so wholeheartedly that it lies in the mtDNA, they are willing to stake their reputations and livelihood on it. The founders of Thunder Bay’s Genesis Genomics Inc. did just that, and are producing some staggering results. This begs the question: have we been looking in the wrong place?
Mr. Greg Rickford, Member of Parliament for Kenora, on behalf of the Honourable Gary Goodyear, Minister of State (Science and Technology), today announced a contribution to Genesis Genomics Inc. from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP).